Option chain shows key data for Artelo Biosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Artelo Biosciences.

Artelo Biosciences (NASDAQ:ARTL) Stock, Option Chain

Artelo Biosciences

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

Screenshot 2024-04-30 at 10.58.41 PM

Biotech

Interview

General

ARTL

&#34;Brand New Science&#34; - This Biotech Is Entering Clinical Studies With What It Says Is Novel Science No One Else Has

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AMKR

AREB

ASXC

ATIF

BASE

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

CHPT

CRVS

CURV

CVGW

DATS

DRTT

EDBL

FOXO

GIII

HKIT

INTA

NBSE

NEOG

PALI

PATH

PLAY

PODD

PXMD

RCLF

SASI

SPWH

STIX

SXTC

TDUP

TNDM

UNIT

VRNT

WHLR

YEXT

Gainers


	American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company&#39;s subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for alternatives to safes made by Liberty Safe.


Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

Pre-Market Outlook

ALAR

MIRA

SISI

THTX

Why WestRock Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Artelo Biosciences Inc

Artelo Biosciences Inc Warrants (18/06/2024)

The billionaire Republican megadonor and Citadel CEO Ken Griffin has expressed openness to selling a minority stake in the $65 billion hedge fund he established in 1990.
What Happened: Griffin has previously sold stakes in his ventures. Two years ago, Sequoia Capital acquired a stake in Citadel Securities for $1.15 billion, valuing the market maker at $22 billion. Recently, Citadel Securities received a $5 billion investment offer from a private equity firm, which Griffin mentioned would help the company remain private longer.
In an <a href="https://www.bloomberg.com/news/articles/2024-11-21/ken-griffin-says-he-s-open-to-selling-minority-stake-in-citadel">interview</a> with&nbsp;Bloomberg on Thursday at the Economic&nbsp;Club of New York, Griffin stated,&nbsp;"We would be open to&nbsp;the possibility of selling a&nbsp;minority stake in Citadel at&nbsp;some point in the future."
Griffin highlighted the challenges of public capital markets, stating,&nbsp;"We need to make being&nbsp;public in the United States&nbsp;a much more attractive proposition."&nbsp;
Despite the offer, Griffin did not confirm acceptance and ruled out taking Citadel Securities public soon. When considering potential partners, Griffin seeks firms similar to Sequoia that can enhance Citadel&#8217;s business operations.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42102652/michael-saylors-microstrategy-takes-wall-street-by-storm-becomes-second-most-traded-stock-after-nvidia?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Michael Saylor&#8217;s MicroStrategy Takes Wall Street By Storm, Becomes Second-Most Traded Stock After Nvidia</a>
Why It Matters:&nbsp;Griffin, a prominent figure in the financial world, has built&nbsp;Citadel&nbsp;into a powerhouse with over $65 billion in assets. As a mega-donor to the Republican Party, he recently voiced concerns over&nbsp;<a href="https://www.benzinga.com/news/global/24/11/42056528/gop-megadonor-ken-griffin-warns-of-slippery-slope-in-trumps-tariff-policies-sees-us-returning-to-the-business-of-business">Donald Trump&#8216;s tariff policies</a>, warning they could hinder U.S. competitiveness. 
In the past year, Citadel has achieved remarkable financial success, <a href="https://www.benzinga.com/general/23/12/36365068/show-me-the-money-inside-ken-griffins-citadels-jaw-dropping-7-billion-return">returning $7 billion to clients </a>after a 30% profit surge. Citadel&#8217;s multistrategy fund, Wellington, has gained nearly 15% year-to-date, making it one of the top-performing hedge funds. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/42102769/floki-beats-dogecoin-shiba-inu-with-double-digit-gains-after-coinbase-listing-announcement?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Floki Beats Dogecoin, Shiba Inu With Double-Digit Gains After Coinbase Listing Announcement</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Photo by Dan G via Flickr

GOP Megadonor Ken Griffin Is 'Open To The Possibility' Of Selling Minority Stake In Citadel

The CNN Money Fear and Greed index showed further improvement in the overall market sentiment, while the index moved to the &#8220;Greed&#8221; zone on Thursday.
U.S. stocks settled higher on Thursday, with the Dow Jomes index gaining more than 450 points during the session.
NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares rose by 0.5% on Thursday after the company posted upbeat earnings and sales results. Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) shares fell 2.2% on Thursday following a report suggesting the company is likely to be investigated under the EU&#8217;s Digital Markets Act next year.
Shares of Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) plunged around 4.7% following the U.S. Department of Justice&#8217;s (DOJ) announcement of sweeping remedies in its high-profile antitrust lawsuit against Google.
On the economic data front, U.S. existing home sales gained by 3.5% from the previous month to an annualized rate of 3.96 million in October. The Philadelphia Fed Manufacturing Index fell to -5.5 in November from 10.3 in the previous month, and compared to market estimates of 8. U.S. initial jobless claims declined by 6,000 from the previous week to 213,000 in the week ending Nov. 16.
Most sectors on the S&amp;P 500 closed on a positive note, with utilities, financials, and consumer staples stocks recording the biggest gains on Thursday. However, consumer discretionary and communication services stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 462 points to 43,870.35 on Thursday. The S&amp;P 500 rose 0.53% to 5,948.71, while the Nasdaq Composite rose 0.03% at 18,972.42 during Thursday's session.
Investors are awaiting earnings results from Destination XL Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) and Global Blue Group Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GB#NYSE">GB</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 57.4, the index moved to the &#8220;Greed&#8221; zone on Thursday, versus a prior reading of 49.6.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42114009/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Long Ideas

AMZN

DXLG

GOOG

GOOGL

NVDA

Dow Surges Over 450 Points As Nvidia Climbs Post-Earnings, Google, Amazon Slip: Fear Index Shifts To 'Greed' Zone

The gross proceeds to the Company from the offering are expected to be approximately $8.2 million, before deducting underwriting discounts, commissions and estimated offering expenses payable by the Company. The Company intends to use the net proceeds from the offering to fund operations and for working capital and general corporate purposes, including capital expenditures. The offering is expected to close on or about November 25, 2024, subject to the satisfaction of customary closing conditions.

MODD

Reported Earlier, Modular Medical Prices $8.2M Public Offering Of 5,450,573 Common Shares At $1.50/Share

The Company intends to use the net proceeds from the Offering for general corporate purposes, including funding future investments, making capital expenditures and funding working capital. The Company has granted the underwriters a 30-day option to purchase up to an additional $7.5 million aggregate principal amount of Notes. The Notes will be issued in minimum denominations of $25.00 and integral multiples of $25.00 in excess thereof. The Offering is expected to close on November 27, 2024.

METC

Reported Earlier, Ramaco Resources Prices $50M Senior Unsecured Notes Offering At 8.375% Interest Due 2029

<ul>
<li>&nbsp;Launch follows approval by Japanese Ministry of Health, Labour and Welfare in September 2024&nbsp;</li>
<li>&nbsp;Milestone payment to be made to HUTCHMED from Takeda&nbsp;</li>
<li>Fruquintinib already launched in several regions including the United States, Europe and China&nbsp;</li>
</ul>

Reported Earlier, HUTCHMED Secures Milestone Payment As Takeda Rolls Out FRUZAQLA In Japanese Market

The New 4.625% Notes will bear interest at a rate of 4.625% per year, to be paid semi-annually on June 23 and December 23, commencing on June 23, 2025. The 9.875% Notes will bear interest at a rate of 9.875% per year, to be paid semi-annually on June 23 and December 23, commencing on June 23, 2025.

Reported Earlier, GrafTech Announces Exchange Offers For $500M And $450M Second Lien Notes Due 2029

With U.S. stock futures trading slightly lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Destination XL Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXLG#NASDAQ">DXLG</a>) to report quarterly earnings at 3 cents per share on revenue of $113.46 million before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. Destination XL shares rose 0.8% to $2.60 in after-hours trading.</li>
<li>The Gap, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>) reported better-than-expected earnings for its second quarter and raised its outlook for FY24 gross margin. The company reported quarterly earnings of 54 cents per share, which beat the analyst consensus estimate of 40 cents per share. Gap shares jumped 15.7% to $25.50 in the after-hours trading session.</li>
<li>Ross Stores, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROST#NASDAQ">ROST</a>) posted stronger-than-expected earnings for its third quarter on Thursday. The company said it sees FY25 earnings of $6.10 to $6.17 per share. Ross Stores shares climbed 7.1% to $153.11 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Intuit Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) reported upbeat results for its first-quarter results, but issued weak forecast for the current quarter. The company reported quarterly earnings of $2.50 per share, which beat the analyst consensus estimate of $2.35 per share. Quarterly revenue came in at $3.28 billion which beat the consensus estimate of $3.14 billion. Intuit shares fell 5% to $644.74 in the after-hours trading session.</li>
<li>Analysts expect Global Blue Group Holding AG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GB#NYSE">GB</a>) to report quarterly earnings at 3 cents per share on revenue of $127.50 million before the opening bell. Global Blue Group shares gained 11.4% to $6.96 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42114009/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields</a></li>
</ul>
Photo courtesy: Gap

INTU

ROST

Gap, Ross Stores And 3 Stocks To Watch Heading Into Friday

Deepwater Asset Management's managing partner Gene Munster has weighed in on the implications of Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google&#8217;s <a href="https://www.benzinga.com/news/24/10/41616230/sundar-pichai-admits-doj-proposals-could-have-unintended-consequences-google-mapping-out-plan-b-in-c">regulatory challenges</a>, including the potential divestment of the Chrome browser.
What Happened: On Thursday, in an interview with CNBC, Munster highlighted the potential impact of a Chrome spin-off on Google&#8217;s search market share.
According to Munster, spinning off Chrome could reduce Google&#8217;s dominant 90% search market share in developed regions to approximately 80%.
This shift could significantly affect Google&#8217;s search growth, which has been averaging 10–14% in recent quarters, potentially dropping to low single digits or even negative in the short term.
He said, &#8220;People love Google, and they will slowly come back,&#8221; but the stock is down about 5% because this gets to the &#8220;core of half their business, which is search.&#8221;&nbsp;
Despite these concerns, he believes the likelihood of a Chrome spinout is low, citing a lack of precedent for such a move.
See Also:&nbsp;<a href="https://www.benzinga.com/media/24/11/42129847/apple-prepares-to-take-on-openais-chatgpt-google-gemini-live-with-llm-siri-in-2025-report">Apple Prepares To Take On OpenAI&#8217;s ChatGPT, Google Gemini &#8216;Live&#8217; With LLM Siri In 2025: Report</a>
Munster also pointed out that Google's search business forms a significant portion of its revenue and is also a critical pillar for its AI initiatives like Gemini. A drop in search market share could weaken Google's ability to compete with rivals such as ChatGPT-parent OpenAI.
He went on to speak about the interconnectedness of regulatory challenges, noting that the DOJ's scrutiny of Google&#8217;s search deal with Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) could further damage the company's search business.
Earlier this year, a lawsuit uncovered that <a href="https://www.benzinga.com/24/11/42083150/googles-20b-search-deal-with-apple-faces-collapse-after-antitrust-ruling-what-it-could-means-for-both-tech-giants?itm_source=parsely-api">Apple received a substantial $20 billion</a> in 2022 to set Google as the default search engine on the Safari browser for iPhones.
For investors, the stakes are high. Munster warned that if such worst-case scenarios unfold, Google's stock could drop another 10–15%.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Tough day for Big Tech on the regulatory front. <a href="https://t.co/kPdWS6xD5T">https://t.co/kPdWS6xD5T</a>
&mdash; Gene Munster (@munster_gene) <a href="https://twitter.com/munster_gene/status/1859758359341301773?ref_src=twsrc%5Etfw">November 22, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The DOJ has been actively pursuing measures to dismantle Google&#8217;s search monopoly, demanding <a href="https://www.benzinga.com/tech/24/11/42105079/googles-unlawful-behavior-stifles-market-entry-for-rivals-doj-says-alphabet-must-sell-chrome-to-end-search-monopoly">Google divest its Chrome browser</a>. This move is part of broader efforts to restore competition in the search market.
The DOJ has also suggested that Google might need to sell its Android operating system if other measures fail.
The impact of these legal actions has been significant, with <a href="https://www.benzinga.com/government/regulations/24/11/42119020/alphabet-bleeds-over-120-billion-in-market-value-eyes-worst-day-in-10-months-after-doj-demands-google-chrome-sale">Alphabet&#8217;s market value</a> dropping by over $120 billion on Thursday, marking its steepest decline since January.
In response to the DOJ&#8217;s push, Perplexity AI&#8217;s CEO has also speculated about acquiring Chrome, while OpenAI is considering developing its <a href="https://www.benzinga.com/markets/24/11/42130303/chatgpt-parent-openai-considers-building-its-own-web-browser-to-challenge-googles-search-monopoly-following-doj-push-to-break-up-chrome-dominance">own web browser to challenge</a> Google&#8217;s dominance.
Price Action: On Thursday, Alphabet's Class A shares fell 4.74%, closing at $167.63, while Class C shares dropped 4.56%, ending at $169.24. In after-hours trading, Class A shares declined an additional 0.42% to $166.93, and Class C shares decreased 0.38%, closing at $168.59, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">data from Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42053801/alphabets-life-sciences-firm-verily-to-become-a-standalone-entity-disconnect-from-google">Alphabet&#8217;s Life Sciences Firm Verily To Become A Standalone Entity, Disconnect From Google</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.
Photo courtesy: Pixabay

Analyst Color

Tech

Media

AAPL

Google's Chrome Battle Goes Beyond The Browser: Gene Munster Outlines Wider Implications Of DOJ Going After The Search Giant

LIFW

Reported Earlier, LifeWallet Secures $2M Pharmaceutical Settlement Amid Broader Efforts To Recover Improper Healthcare Payments And Partner With Government Efficiency Initiatives

American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) is taking aim at &#8220;gate lice&#8221; &#8211; an industry term for passengers who crowd gates before their boarding group is called &#8211; with new technology being rolled out to <a href="https://www.benzinga.com/24/11/42076876/what-could-trumps-new-dot-pick-mean-for-evs-airlines-railroads">more than 100 U.S. airports during the holiday season</a>.
What Happened: The system, which automatically rejects boarding passes from passengers attempting to board ahead of their assigned group, comes as a welcome relief to airline staff who have long struggled with boarding zone violations.
&#8220;We&#8217;ve heard from our customers that the ability to board with their assigned group is important,&#8221; said Julie Rath, Senior Vice President of Airport Operations, Reservations and Service Recovery at American Airlines. &#8220;The initial positive response from customers and team members has exceeded our expectations.&#8221;
The technology triggers an audible alert if passengers try to board early, allowing gate agents to redirect them to wait for their proper boarding group. 
Following successful trials at airports in Albuquerque, Washington D.C., and Tucson, the expansion will include major facilities such as Austin-Bergstrom International Airport and Hartsfield-Jackson Atlanta International Airport.
See Also: <a href="https://www.benzinga.com/news/global/24/11/42130782/amazon-at-risk-of-major-fine-as-eu-investigates-alleged-preference-for-in-house-products-under-digital-markets-act-report">Amazon At Risk Of Major Fine As EU Investigates Alleged Preference For In-House Products Under Digital Markets Act: Report</a>
Why It Matters: Flight attendants and gate staff have long identified premature boarding attempts as a significant source of frustration, leading to the informal &#8220;gate lice&#8221; nickname for chronic offenders. The new system aims to eliminate such disruptions while preserving boarding privileges tied to &#8220;AAdvantage&#8221; status and fare class.
The software platform also provides gate agents with real-time data on boarding group sizes and incoming flight connections, consolidating multiple applications into a single interface. For passengers traveling with companions in earlier boarding groups, agents can override the system with a single click.
American Airlines, which operates thousands of daily flights to more than 350 destinations across 60+ countries, plans to extend the technology to its hub airports in the coming months.
Price Action: American Airlines&#8217; stock closed at $14.20 on Tuesday, down 1.80% for the day. In after-hours trading, the stock edged up 0.21%. Year-to-date, the stock has gained 5.65%, according to <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42130859/as-trump-backs-drill-baby-drill-his-doge-co-lead-elon-musk-believes-all-energy-generation-will-be-solar-heres-what-ubs-recommends-after-election-dip">As Trump Backs &#8216;Drill Baby, Drill,&#8217; His DOGE Co-Lead Elon Musk Believes &#8216;All Energy Generation Will Be Solar&#8217; — Here&#8217;s What UBS Recommends After Election Dip</a></li>
</ul>
Image Via Pixabay
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" target="_blank" rel="noreferrer noopener"></a>

Equities

Travel

American Airlines Targets 'Gate Lice' With New Boarding Tech At 100+ Airports This Holiday Season

Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) will release earnings results for the third quarter, before the <a href="https://www.benzinga.com/quote/BBWI/earnings">opening bell on Monday, Nov. 25.</a>
Analysts expect Bath &amp; Body Works to report quarterly earnings at 47 cents per share. That's down from 48 cents per share a year ago. The Columbus, Ohio-based company projects to report quarterly revenue of $1.58 billion, compared to $1.56 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Nov. 8, Bath &amp; Body Works announced the declaration of its regular quarterly dividend of 20 cents per share payable on Dec. 6, to shareholders of record at the close of business on Nov. 22.
Bath &amp; Body Works shares gained 0.8% to close at $30.75 on Thursday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/BBWI/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Wells Fargo analyst Ike Boruchow maintained an Equal-Weight rating and cut the price target from $35 to $32 on Nov. 6. This analyst has an accuracy rate of 66%.</li>
<li>BMO Capital analyst Simon Siegel reiterated an Outperform rating and lowered the price target from $52 to $50 on Aug. 29. This analyst has an accuracy rate of 75%.</li>
<li>Goldman Sachs analyst Kate McShane maintained a Buy rating and cut the price target from $60 to $49 on Aug. 29. This analyst has an accuracy rate of 69%.</li>
<li>JP Morgan analyst Matthew Boss maintained a Neutral rating and slashed the price target from $42 to $39 on Aug. 29. This analyst has an accuracy rate of 67%.</li>
<li>Raymond James analyst Olivia Tong maintained a Neutral rating and cut the price target from $51 to $42 on Aug. 29. This analyst has an accuracy rate of 66%.</li>
</ul>
Considering buying BBWI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="550" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22011415/image-238-1024x550.png" alt="" class="wp-image-660295" style="width:678px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22011415/image-238-1024x550.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22011415/image-238-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22011415/image-238-768x413.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22011415/image-238.png 1232w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42114009/wall-streets-most-accurate-analysts-weigh-in-on-3-health-care-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields</a></li>
</ul>

Price Target

Analyst Ratings

BBWI

Bath & Body Works Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk on Thursday tempered down customer expectations of purchasing the company&#8217;s dedicated robotaxi offering &#8211; <a href="https://www.benzinga.com/topic/tesla-cybercab">the Cybercab</a> &#8211; and its humanoid robot called <a href="https://www.benzinga.com/topic/optimus">Optimus</a> for about $30,000 each, saying it would be possible only on the &#8220;long-term.&#8221;
What Happened: Production needs to exceed a million a year before the company can sell the two products for about $30,000, Musk said. 
&#8220;We need to reach >1M/year production volumes, but, long-term, yes,&#8221; he wrote in a post on X, without clarifying if he is hinting towards a collective production volume of a million or a million individually for both the products.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We need to reach &gt;1M/year production volumes, but, long-term, yes <a href="https://t.co/WE39TnhTdf">https://t.co/WE39TnhTdf</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1859656599897506229?ref_src=twsrc%5Etfw">November 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Tall Promises: During Tesla's annual shareholder meeting in June, Musk said that there will be at least&nbsp;<a href="https://www.benzinga.com/news/24/06/39246781/elon-musk-thinks-humanoid-robots-will-one-day-exceed-human-population-from-nvidias-project-gr00t-to" target="_blank" rel="noreferrer noopener">one humanoid robot</a>&nbsp;for every person in the world in the future, implying a total humanoid robot population of at least 10 billion or more, of which the EV company will have a significant share.
Musk then said that he expects to be&nbsp;<a href="https://www.benzinga.com/news/24/03/37950895/elon-musk-says-cost-of-making-an-optimus-is-half-that-of-manufacturing-a-tesla-ev-despite-complexity" target="_blank" rel="noreferrer noopener">able to sell Optimus at a price point below $30,000</a> once it reaches high-volume production.
In July, the CEO said that the EV company would have "genuinely useful" humanoid robots in low production for use within its factories next year. The company will "hopefully" increase production for other customers in 2026, he said.
As for the Cybercab, Tesla unveiled the car with no pedals or steering wheel in October. The vehicle, CEO&nbsp;Elon Musk&nbsp;then said, will enter production "before 2027" and be priced below $30,000.
History Of Underdelivering: Musk is known for providing price points that the company cannot deliver. 
During the Cybertruck&#8217;s unveiling in November 2019, Musk presented tentative pricing for the stainless steel truck. The dual-motor all-wheel-drive (AWD) variant was projected to begin at $49,900 but is now priced at $79,990 in the U.S.
The top-tier tri-motor all-wheel drive was projected to start at $69,900 but is now priced<a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/12/36039263/did-tesla-overpromise-and-underdeliver-with-the-cybertruck"> at a whopping $99,990</a>. 
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42058338/byd-makes-a-million-nevs-in-less-than-2-months" target="_blank" rel="noreferrer noopener">BYD Makes A Million NEVs In Less Than 2 Months After Beating Tesla For The First Time Since 2022 In Quarterly Revenue</a></li>
</ul>
Photo courtesy: Tesla

TSLA

Tesla CEO Elon Musk Tries To Lower Expectations Of $30K Optimus Or Cybercab

Q3 2024 Operating Highlights:
<ul>
<li>Successfully completed funded research phase of the Indivior collaboration with both Indivior and Addex each selecting GABAB PAM drug candidate for further development in SUD and chronic cough, respectively</li>
<li>Completed Q3 2024 with cash and cash equivalents of CHF3.3 million</li>
</ul>

ADXN

Addex Therapeutics Reported Q3 EPS Of CHF(0.02) Up From CHF(0.03), Cash Balance Of CHF3.35M

Macro Economic Events

Econ #s

Economics

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, au Jibun Bank Japan Services Purchasing Managers' Index Preliminary For November 50.2 Vs. 49.7 Prior

Reported Earlier, Japan National Core Consumer Price Index (YoY) For October 2.3% Vs. 2.2% Est.; 2.4% Prior

Renewable energy stocks present a buying opportunity despite recent electoral headwinds, according to UBS analysts, while Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk continues to <a href="https://www.benzinga.com/news/24/09/41059891/elon-musk-says-because-almost-none-of-you-do-your-math-sums-the-world-is-largely-not-using-the-big-f">advocate solar power&#8217;s future dominance</a>.
What Happened: UBS analysts on Thursday elevated U.S. and EU renewables to their top-ranking stock theme, citing an attractive entry point following steep post-election losses, <a href="https://markets.businessinsider.com/news/stocks/renewable-energy-stocks-election-trump-power-demand-data-centers-ubs-2024-11">reported</a> Business Insider. 
The announcement comes as clean energy shares have tumbled, with companies like Plug Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) and Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) down over 24% since President-elect Donald Trump&#8216;s victory.
&#8220;The environment of an unrelenting power demand shock puts just about every source of power generation in a solid position to capitalize,&#8221; UBS analysts wrote, pointing to surging power needs from artificial intelligence data centers and corporate sustainability goals.
The analysts remain optimistic despite Trump&#8217;s expected scaling back of President Joe Biden-era clean energy initiatives. They argue that companies could &#8220;grandfather&#8221; existing subsidies and that state-level emission goals will sustain industry growth. 
See Also: <a href="https://www.benzinga.com/news/global/24/11/42129914/jim-cramer-doubles-down-on-nvidia-demand-is-accelerating-as-ai-customers-have-no-choice-but-to-buy-its-chips">Jim Cramer Doubles Down On Nvidia: &#8216;Demand Is Accelerating&#8217; As AI Customers &#8216;Have No Choice&#8217; But To Buy Its Chips</a>
This view comes as Trump, <a href="https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently">who has appointed Musk</a> and Vivek Ramaswamy to co-lead his new Department of Government Efficiency named after cryptocurrency Dogecoin, advocates for increased drilling.
Musk, despite his new role in the incoming Trump administration, has historically remained bullish on renewable energy. &#8220;Once you understand Kardashev Scale, it becomes utterly obvious that essentially all energy generation will be solar,&#8221; he posted on X. He noted that a single square mile receives <a href="https://www.benzinga.com/news/24/09/41059891/elon-musk-says-because-almost-none-of-you-do-your-math-sums-the-world-is-largely-not-using-the-big-f">approximately 2.5 gigawatts of solar energy</a>.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Once you understand Kardashev Scale, it becomes utterly obvious that essentially all energy generation will be solar. Also, just do the math on solar on Earth and you soon figure out that a relatively small corner of Texas or New Mexico can easily serve all US electricity.
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1839439841337225277?ref_src=twsrc%5Etfw">September 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
UBS recommends several stocks poised for gains, including NextEra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEE#NYSE">NEE</a>) and Generac Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNRC#NYSE">GNRC</a>) in the U.S., along with European players like Iberdrola (OTC:<a class="ticker" href="https://www.benzinga.com/stock/IBDRY#OTC">IBDRY</a>), Siemens Energy (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SMEGF#OTC">SMEGF</a>), and Orsted (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DOGEF#OTC">DOGEF</a>). The analysts cite historical precedent, noting that solar installations grew 50% during Trump&#8217;s previous term.
The renewable sector&#8217;s growth potential is further supported by expanding applications, including Musk&#8217;s recent suggestion that SpaceX&#8217;s Starlink satellite network could integrate <a href="https://www.benzinga.com/news/24/10/41648885/spacex-ceo-elon-musk-agrees-that-starlink-could-combine-hardware-with-solar-panels-and-batteries">solar panels and batteries into its hardware offering</a>.
While Trump&#8217;s &#8220;drill baby, drill&#8221; <a href="https://www.benzinga.com/news/24/09/40703958/trumps-drill-baby-drill-pledge-may-not-deliver-promised-energy-price-cuts-experts-warn">stance has rattled markets</a>, UBS maintains that investor concerns about the sector&#8217;s future may be &#8220;overdone,&#8221; as corporate and state-level commitments to clean energy persist alongside growing power demands from emerging technologies.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42127938/bitcoin-analyst-warns-of-4-6-flash-crashes-before-year-end-as-it-inches-closer-to-100k-thats-the-moment-altcoins-shoot-off">Bitcoin Analyst Warns Of &#8216;4-6 Flash Crashes&#8217; Before Year-End As It Inches Closer To $100K: That&#8217;s The Moment Altcoins &#8216;Shoot Off&#8217;</a></li>
</ul>
Photo via Unsplash
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

DOGEF

ENPH

GNRC

IBDRY

PLUG

SMEGF

As Trump Backs 'Drill Baby, Drill,' His DOGE Co-Lead Elon Musk Believes 'All Energy Generation Will Be Solar' — Here's What UBS Recommends After Election Dip

The EU is reportedly set to investigate Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) in 2025 for favoring its in-house branded products.
What Happened: The EU is preparing a case against Amazon under its Digital Markets Act or DMA, reported Reuters, citing people with direct knowledge of the matter.
The probe will focus on whether Amazon&#8217;s marketplace gives an unfair advantage to its own products over those sold by third-party vendors. If Amazon is found to be in violation of the DMA, it could be hit with a fine amounting to 10% of its global annual turnover.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42101690/amazon-remains-best-idea-in-e-commerce-this-holiday-season-jpmorgan-analyst-says">Amazon Remains &#8216;Best Idea&#8217; In E-Commerce This Holiday Season, JPMorgan Analyst Says</a>
The decision to launch the investigation will be made by the incoming EU antitrust chief, Teresa Ribera, in the upcoming months.
Amazon did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga's</a> request for comments.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The DMA, which was implemented last year, prohibits Amazon and six other big tech firms from favoring their products and services on their platforms.
In January, Amazon&#8217;s <a href="https://www.benzinga.com/government/24/01/36688100/amazons-irobot-deal-faces-likely-rejection-from-eu-competition-watchdog-report">$1.7-billion acquisition</a> of iRobot Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRBT#NASDAQ">IRBT</a>), was abandoned due to opposition from the EU&#8217;s competition watchdog.
Earlier this week, Amazon and Elon Musk-led SpaceX's efforts to block cases brought by the National Labor Relations Board or NLRB also <a href="https://www.benzinga.com/24/11/42054405/amazon-and-spacexs-efforts-to-block-nlrb-cases-in-jeopardy-as-appeals-court-raises-key-legal-concerns">faced obstacles</a>.
Amazon is contesting a case involving its first union at a warehouse in New York City.
Last month, Amazon reported a <a href="https://www.benzinga.com/news/earnings/24/10/41664778/amazon-q3-earnings-highlights-revenue-beat-eps-beat-q4-guidance-new-kindles-significantly-outperfor">successful third quarter</a> in 2024, with net sales of $158.9 billion, an 11% increase year-over-year, beating the Street consensus estimate of $157.2 billion.
Price Action: Amazon shares closed Thursday&#8217;s session down 2.22% at $198.38. In after-hours trading, the stock dropped further, reaching $198.08 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41692259/amazon-analysts-see-growth-ahead-with-aws-in-early-innings-of-a-big-ai-cycle-advert">Amazon Analysts See Growth Ahead With AWS In &#8216;Early Innings Of A Big AI Cycle,&#8217; Advertising Segment Fast-Growing &#8216;Hidden Asset&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Legal

Global

IRBT

Amazon At Risk Of Major Fine As EU Investigates Alleged Preference For In-House Products Under Digital Markets Act: Report

Bitcoin&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) surge toward $100,000 could face a significant pullback due to excessive market leverage, Galaxy Digital Holdings Ltd. CEO Mike Novogratz warned in a recent interview, even as the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42127938/bitcoin-analyst-warns-of-4-6-flash-crashes-before-year-end-as-it-inches-closer-to-100k-thats-the-moment-altcoins-shoot-off">cryptocurrency continues setting new records</a>.
What Happened: The billionaire investor highlighted concerning levels of leverage in the crypto ecosystem. &#8220;There&#8217;s a ton of leverage in the system right now,&#8221; Novogratz <a href="https://www.youtube.com/watch?v=QPiWKHHiXyY">said</a> on CNBC. &#8220;The crypto community is levered to the gills, and so there will be a correction.&#8221;
While Novogratz maintains that Bitcoin reaching $100,000 is &#8220;inevitable&#8221; &#8211; with prices recently touching $99,000 &#8211; he projects a potential retreat to $80,000 during a correction phase. This would represent a 20% decline from the six-digit milestone.
The warning comes amid broader market developments, including MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), completing a $3 billion <a href="https://www.benzinga.com/trading-ideas/movers/24/11/42126020/whats-going-on-with-microstrategy-stock-after-the-bell">convertible note offering to acquire additional Bitcoin</a>. The company currently holds 331,200 Bitcoin which it purchased at an average price of $49,874 per coin.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42125642/bitcoin-ethereum-dogecoin-prepping-for-an-early-thanksgiving-btc-is-currently-less-than-one-eth-away-from-100000-says-trader">Bitcoin, Ethereum, Dogecoin Prep For Early Thanksgiving: &#8216;BTC Is Currently (Less Than) One ETH Away From $100,000,&#8217; Says Trader</a>
Supporting Novogratz&#8217;s cautionary stance, cryptocurrency analyst Michaël van de Poppe forecasts &#8220;4-6 flash crashes&#8221; before year-end, with Bitcoin potentially <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42127938/bitcoin-analyst-warns-of-4-6-flash-crashes-before-year-end-as-it-inches-closer-to-100k-thats-the-moment-altcoins-shoot-off">dropping 5-10% in single-day moves</a>. Alternative cryptocurrencies could see even steeper declines of 20-30%.
Why It Matters: Despite these concerns, Novogratz expressed optimism about crypto&#8217;s regulatory outlook under President-elect Donald Trump&#8216;s administration. &#8220;The entire cabinet almost owns bitcoin, and are proponents of digital assets,&#8221; he noted, suggesting a &#8220;paradigm shift&#8221; in cryptocurrency regulation.
The current crypto market surge has pushed total market capitalization to $3.3 trillion, with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) trading at $3,359 and Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) reaching $262. Bitcoin currently trades at $98,563, maintaining its upward trajectory despite warnings of potential corrections.
&#8220;Normally you hit 100, you bounce off a bit,&#8221; Novogratz concluded while acknowledging the possibility of higher prices due to limited supply and strong demand, particularly from Middle Eastern investors and public equity markets.
Price Action: Bitcoin is currently trading at $99,138, up nearly 2.4% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro data</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42127938/bitcoin-analyst-warns-of-4-6-flash-crashes-before-year-end-as-it-inches-closer-to-100k-thats-the-moment-altcoins-shoot-off">Bitcoin Analyst Warns Of &#8216;4-6 Flash Crashes&#8217; Before Year-End As It Inches Closer To $100K: That&#8217;s The Moment Altcoins &#8216;Shoot Off&#8217;</a></li>
</ul>
Image Via Pixabay
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$SOL

MSTR

Bitcoin's Path To $100K 'Inevitable' But Crypto Community Is 'Leveraged To The Gills,' Warns Galaxy's Mike Novogratz, Predicts Correction To $80K Ahead

Silicon Valley billionaire and venture capitalist <a href="https://www.benzinga.com/news/24/09/41086806/elon-musk-mocks-vinod-khosla-after-openai-investor-mixes-up-argentinas-poverty-and-unemployment-rate">Vinod Khosla</a> has issued a bold prediction: artificial intelligence (AI) will replace most human jobs over the next 25 years.&nbsp;
In a recent blog post, Khosla wrote about the implications of AI and warned that "80% of 80% of all jobs, maybe more, can be done by AI, be it primary care doctors, psychiatrists, sales people, oncologists, farmworkers or assembly line workers, structural engineers, chip designers, you name it."
Don't Miss:
<ul>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace — <a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv" target="_blank" rel="noreferrer noopener">here&#8217;s a breakdown on how on what&#8217;s behind this formula.</a></li>
<li>Can you guess how many retire with a $5,000,000 nest egg? &#8211;<a href="https://www.benzinga.com/money/retire-5mil-nest-egg"> How does it compare to the average?</a></li>
<li> The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
Khosla's experience gives weight to his predictions. He cofounded Sun Microsystems and has invested heavily in tech giants like Amazon, Google and <a href="https://www.benzinga.com/news/24/09/41078513/openai-plans-to-more-than-double-chatgpt-price-over-next-5-years-report">OpenAI</a>. He has also spent over four decades studying disruptive technology and believes that AI will do most jobs "better, faster and cheaper" than humans, drastically changing the labor market.&nbsp;
<h2 class="wp-block-heading">A World Without Jobs</h2>
According to his blog, Khosla says that AI will create a world where human labor isn't necessary for most tasks. It can assist with and perform tasks like assembly line work, investment banking and even medical diagnosis.&nbsp;
The warnings Khosla discusses surrounding AI aren't meant to spread fear but to advocate for proactive solutions as our world heads in this direction. He talks about the risk of an "economic dystopia," where wealth becomes increasingly concentrated at the top – more so than it is now – and both intellectual and physical labor lose their value.&nbsp;
Khosla states that if governments don't proactively identify this problem and devise solutions for AI taking over jobs, millions could face <a href="https://www.benzinga.com/markets/equities/24/09/40760261/biden-administration-says-unemployment-is-low-but-do-americans-see-it-that-way">unemployment</a>.&nbsp;
Trending: This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a>
<h2 class="wp-block-heading">The Case for Universal Basic Income (UBI)</h2>
According to Khosla, universal basic income (UBI) is one solution to the looming AI job crisis. UBI is a government program that regularly provides every adult citizen with a set amount of money to help alleviate poverty.&nbsp;
Khosla believes that UBI will become essential as AI replaces jobs. It can provide a safety net for those whose jobs become automated. "As AI reduces the need for human labor, UBI could become crucial, with governments playing a key role in regulating AI's impact and ensuring equitable wealth distribution," he wrote.
The concept of UBI isn't new, but it has gained renewed attention as automation accelerates. Khosla joins a growing list of Silicon Valley figures, including Sam Altman and Mark Zuckerberg, who advocate for UBI to cushion the economic disruption caused by AI.
Trending: ‘Scrolling to UBI': Deloitte's #1 fastest-growing software company allows users to earn money on their phones –<a href="https://www.benzinga.com/money/mode-mobile-2"> invest today with $1,000 for just $0.25/share</a>
<h2 class="wp-block-heading">A Shorter Workweek and More Meaningful Life</h2>
While Khosla spoke about AI&#8217;s challenges, he also presented several upsides, one of which is a shorter workweek. He envisions a world where AI handles mundane, labor-intensive jobs, freeing people up to take on more fulfilling activities. He believes that with the right policies, AI could bring about a three-day workweek, where people can focus more on hobbies, spend time with loved ones and enjoy life more.&nbsp;
"Life won't become less meaningful once we eradicate undesirable, toil-intensive jobs," he wrote. "Quite the opposite – life will become more meaningful as the need to work 40 hours per week could disappear within a few decades for those countries that adapt to these technologies."
Trending: Invest in $20+ trillion home equity market today across cities like Austin, Miami, and Los Angeles through a <a href="https://www.benzinga.com/money/nada-cityfunds">unique 5-year term fund targeting a 14-20% IRR with minimums as low as $2,500</a>
<h2 class="wp-block-heading">Balancing AI Innovation and Regulation</h2>
According to <a href="https://www.cnn.com/2024/11/19/tech/ai-risks-trump-elon-musk-intl/index.html">CNN article</a>, Elon Musk has consistently voiced concerns that AI could pose an existential threat to humanity, despite his company, xAI, developing a generative AI chatbot. Musk supported a proposed California bill designed to address catastrophic risks of AI systems becoming uncontrollable. However, Governor Gavin Newsom vetoed the bill, citing potential harm to innovation. Musk's worries align with suggestions that AI regulation might feature in future executive orders.
Within Trump's circle, opinions on AI regulation vary. JD Vance, the incoming vice-president, warned that excessive regulation could solidify dominance for established tech giants, stifling new innovators crucial for American growth. Interestingly, Musk's Tesla, a major tech player, is heavily invested in AI. The company highlighted its commitment to AI advancements in its latest earnings report, emphasizing its role in shaping the future of innovation.
Musk's dual stance highlights the tension between advocating for AI safety and fostering AI-driven progress.
This story was previously reported and have been updated to reflect post-election players in AI.
Read Next:
<ul>
<li>If there was a new fund backed by Jeff Bezos offering a 7-9% target yield with monthly dividends<a href="https://www.benzinga.com/money/arrived-private-credit-fund"> would you invest in it</a>?</li>
<li>How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.</li>
</ul>

Personal Finance

AI Will Do Most Jobs 'Better, Faster, Cheaper': Silicon Valley Billionaire Vinod Khosla Calls For Universal Basic Income

ChatGPT-parent OpenAI is reportedly considering developing a web browser to challenge Alphabet Inc. subsidiary (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google&#8217;s dominance. This follows the U.S. Department of Justice's <a href="https://www.benzinga.com/government/regulations/24/11/42119020/alphabet-bleeds-over-120-billion-in-market-value-eyes-worst-day-in-10-months-after-doj-demands-google-chrome-sale">push for Google to divest Chrome browser</a>.
What Happened: OpenAI has discussed its plans with app and website developers, including notable names like Conde Nast, Redfin, Eventbrite, and Priceline, <a href="https://www.theinformation.com/articles/openai-considers-taking-on-google-with-browser">reported</a> The Information, citing people familiar with the development.
The idea is to develop a web browser that would integrate with its chatbot. The AI startup has also discussed or secured deals to power search features including travel, food, retail websites, and real estate.
See Also:&nbsp;<a href="https://www.benzinga.com/tech/24/11/42123646/google-anthropic-deal-in-jeopardy-as-us-justice-department-looks-to-snap-online-search-monopoly">Google, Anthropic Deal In Jeopardy As US Justice Department Looks To Snap Online Search Monopoly</a>
OpenAI has also been in talks to provide AI features for Samsung Electronics Co.'s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>) devices, a <a href="https://www.benzinga.com/markets/equities/24/07/39711663/samsung-unveils-phones-with-gemini-ai-integration-but-hikes-prices-will-customers-budge">major partner of Google</a>, the report noted.
The ChatGPT-maker already has a partnership with Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), according to which it powers the &#8220;Apple Intelligence&#8221; features on the company's new devices.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Sam Altman-led OpenAI has already <a href="https://www.benzinga.com/news/24/10/41663190/openai-rolls-out-chatgpt-search-google-shares-slide">ventured into the search</a> space with its SearchGPT product.
Meanwhile, Google's hold on the search market has come under scrutiny. On Thursday, DOJ argued that Google's control of Chrome is a form of antitrust monopoly.
Alphabet's shares fell more than 6% in Thursday morning trading in New York, witnessing its largest drop since January 2024.
This decline erased over $120 billion in market value, pushing Alphabet&#8217;s valuation below the $2 trillion mark.
At the time of writing, Alphabet's market capitalization was at $2.063 trillion, making it the fifth most valuable company in the world now following Nvidia Corp., Apple, Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Amazon.com Inc.
Earlier this year an internal email from Microsoft surfaced, indicating that the company&#8217;s investment in OpenAI was <a href="https://www.benzinga.com/news/24/05/38582364/microsofts-fear-of-googles-ai-dominance-led-to-openai-investment-internal-email-reveals-were-multipl">motivated by fears</a> of lagging behind Alphabet&#8217;s AI advancements.
Since 2019, Microsoft has invested roughly $14 billion in ChatGPT-parent.
Price Action: On Thursday, Alphabet's Class A shares dropped 4.74%, ending at $167.63, while Class C shares decreased 4.56%, closing at $169.24. After hours, Class A shares fell another 0.42% to $166.93, and Class C shares slipped 0.38% to $168.59, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">data from Benzinga Pro</a>.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/tech/24/11/42105079/googles-unlawful-behavior-stifles-market-entry-for-rivals-doj-says-alphabet-must-sell-chrome-to-end-search-monopoly">Google&#8217;s &#8216;Unlawful Behavior&#8217; Stifles Market Entry For Rivals: DOJ Says Alphabet Must Sell Chrome To End Search Monopoly</a></li>
</ul>
Photo courtesy: Shutterstock

MSFT

SSNLF

ChatGPT-Parent OpenAI Considers Building Its Own Web Browser To Challenge Google's Search Monopoly, Following DOJ Push To Break Up Chrome Dominance

Vernon Bernardino, an analyst from H.C. Wainwright, reiterated the Buy rating on Artelo Biosciences (ARTL – Research Report). The associated price ...

Artelo Biosciences' Drug Portfolio Progress Bolsters Buy Rating: Analyst Vernon Bernardino Forecasts Significant Clinical Milestones

Analyst Michael Higgins of Ladenburg Thalmann & Co. maintained a Buy rating on Artelo Biosciences (ARTL – Research Report), retaining the price tar...

Buy Rating Affirmed for Artelo Biosciences on Strong Clinical Pipeline and Solid Financial Health

In a report released yesterday, Jason McCarthy from Maxim Group maintained a Buy rating on Artelo Biosciences (ARTL – Research Report), with a pric...

Buy Rating on Artelo Biosciences Amidst Promising Clinical Advancements and Portfolio Diversification

Maxim Group analyst Jason McCarthy maintained a Buy rating on Artelo Biosciences (ARTL – Research Report) yesterday and set a price target of $5.00...

Optimistic Buy Rating for Artelo Biosciences Amidst Growing Focus on Cancer Cachexia Therapies

Artelo Biosciences GAAP EPS of -$0.35 beats by $0.44

Artelo Biosciences (ARTL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Vernon Bernardino...

Positive Outlook for Artelo Biosciences: Promising Pipeline and Key Catalysts Drive Buy Rating

Artelo Biosciences (ARTL) announced new data being presented today on ART26.12, Artelo's lead clinical Fatty Acid Binding Protein 5, FABP5, inhibit...

Artelo Biosciences announces new data on novel non-opioid treatment for OA pain

Artelo Biosciences ( ($ARTL) ) has released its Q3 earnings. Here is a breakdown of the information Artelo Biosciences presented to its investors. ...

Artelo Biosciences Reports Q3 2024 Financials and Progress

Promising Outlook for Artelo Biosciences: Buy Rating Backed by Strong Pipeline and Strategic Positioning

The company states: "Artelo Biosciences (ARTL) announced that Professor Saoirse O'Sullivan, Vice President of Translational Sciences at Artelo, wil...

Artelo Biosciences to present key data on 3 development programs

Health Care

Press Releases

Artelo Biosciences Announces Data Supporting Broad Potential Utility of its FABP Inhibitor Platform

Artelo Biosciences Presents Comparative Data from Key Preclinical Studies on ART12.11 at the 34th Annual International Cannabinoid Research Society Symposium

Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor

Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

Artelo Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Artelo Biosciences CEO to Participate in Fireside Chat at the Maxim Group Virtual Healthcare Summit on October 16th

Artelo Biosciences Announces Acceptance of ART26.12 into the National Institutes of Health's "Preclinical Screening Platform for Pain" Program

Artelo Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update

Artelo Biosciences Announces Promising New Data on Novel Non-Opioid Treatment Approach for Osteoarthritis Pain at the 13th Annual Musculoskeletal Repair and Regeneration Symposium

Artelo Biosciences to Present Key Data on Three Development Programs at the 7th Cannabinoid Drug Development Summit

Comments

Artelo Biosciences

Artelo Biosciences (ARTL) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga